Recurrent Ovarian Cancer With High Folate Receptor Alpha Expression clinical trials

Explore recruiting recurrent ovarian cancer with high folate receptor alpha expression clinical trials.

Recruiting recurrent ovarian cancer with high folate receptor alpha expression studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Recurrent Ovarian Cancer With High Folate Receptor Alpha Expression trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized Phase 2 Study of Ocular Toxicity Evaluation and Mitigation During Treatment with Mirvetuximab Soravtansine in Patients with Recurrent Ovarian Cancer with High Folate Receptor-Alpha Expression

Spain, France, Ireland, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Recurrent Ovarian Cancer With High Folate Receptor Alpha Expression trials by city

Recurrent Ovarian Cancer With High Folate Receptor Alpha Expression in Toronto Recurrent Ovarian Cancer With High Folate Receptor Alpha Expression in Vancouver Recurrent Ovarian Cancer With High Folate Receptor Alpha Expression in Montreal Recurrent Ovarian Cancer With High Folate Receptor Alpha Expression in Calgary Recurrent Ovarian Cancer With High Folate Receptor Alpha Expression in Edmonton Recurrent Ovarian Cancer With High Folate Receptor Alpha Expression in Ottawa Recurrent Ovarian Cancer With High Folate Receptor Alpha Expression in Winnipeg Recurrent Ovarian Cancer With High Folate Receptor Alpha Expression in Quebec City Recurrent Ovarian Cancer With High Folate Receptor Alpha Expression in Hamilton Recurrent Ovarian Cancer With High Folate Receptor Alpha Expression in Kitchener Recurrent Ovarian Cancer With High Folate Receptor Alpha Expression in London Recurrent Ovarian Cancer With High Folate Receptor Alpha Expression in Halifax Recurrent Ovarian Cancer With High Folate Receptor Alpha Expression in New York Recurrent Ovarian Cancer With High Folate Receptor Alpha Expression in Los Angeles Recurrent Ovarian Cancer With High Folate Receptor Alpha Expression in Chicago Recurrent Ovarian Cancer With High Folate Receptor Alpha Expression in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease